For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $17.62 in the prior trading day, Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed at $17.50, down -0.68%. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 1.87 million shares were traded. SBRA stock price reached its highest trading level at $17.855 during the session, while it also had its lowest trading level at $17.465.
Ratios:
Our goal is to gain a better understanding of SBRA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 62.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.41. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.89.
On January 07, 2025, JMP Securities Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $20.
Mizuho Downgraded its Outperform to Neutral on December 05, 2024, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 24 ’25 when Cusack Catherine bought 1,500 shares for $15.92 per share. The transaction valued at 23,880 led to the insider holds 60,583 shares of the business.
Cusack Catherine bought 1,000 shares of SBRA for $16,435 on Feb 21 ’25. The Director now owns 59,083 shares after completing the transaction at $16.43 per share. On May 22 ’24, another insider, Cusack Catherine, who serves as the Director of the company, bought 7,000 shares for $14.43 each. As a result, the insider paid 101,010 and bolstered with 46,385 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 4163442688 and an Enterprise Value of 6507446784. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.67, and their Forward P/E ratio for the next fiscal year is 22.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.31. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.94 while its Price-to-Book (P/B) ratio in mrq is 1.52. Its current Enterprise Value per Revenue stands at 9.261 whereas that against EBITDA is 15.45.
Stock Price History:
The Beta on a monthly basis for SBRA is 0.83, which has changed by 0.25538015 over the last 52 weeks, in comparison to a change of 0.07545352 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $19.99, while it has fallen to a 52-week low of $13.46. The 50-Day Moving Average of the stock is 2.48%, while the 200-Day Moving Average is calculated to be 0.72%.
Shares Statistics:
The stock has traded on average 2.48M shares per day over the past 3-months and 2155480 shares per day over the last 10 days, according to various share statistics. A total of 237.59M shares are outstanding, with a floating share count of 233.61M. Insiders hold about 1.81% of the company’s shares, while institutions hold 98.56% stake in the company. Shares short for SBRA as of 1743379200 were 19020978 with a Short Ratio of 7.67, compared to 1740700800 on 17045198. Therefore, it implies a Short% of Shares Outstanding of 19020978 and a Short% of Float of 11.3900006.
Dividends & Splits
In the trailing 12 months, SBRA’s forward annual dividend rate was 1.2, compared to 1.20 this year. Against a Trailing Annual Dividend Yield of 0.06810442The stock’s 5-year Average Dividend Yield is 8.66. The current Payout Ratio is 223.55% for SBRA, which recently paid a dividend on 2025-02-14 with an ex-dividend date of 1739491200. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
